Načítá se...
Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains
INTRODUCTION: Clinically, significant stroke injury results from ischemia-reperfusion (IR), which induces a deleterious biphasic opening of the blood-brain barrier (BBB). Tissue plasminogen activator (tPA) remains the sole pharmacological agent to treat ischemic stroke. However, major limitations of...
Uloženo v:
| Vydáno v: | Exp Neurol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609039/ https://ncbi.nlm.nih.gov/pubmed/32147438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2020.113275 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|